GlaxoSmithKline (GSK) has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for its regulatory ...

In this Q&A, He discussed Boehringer's investments in AI as well as areas where the technology could deliver greater value for pharma.

GlaxoSmithKline (GB:GSK) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium - Now ...

Big Pharma allows millions of people to alleviate debilitating pain, manage dangerous and chronic diseases, mitigate their ...

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he average down on this FTSE 100 ...

As the Indian Pharmaceutical Market (IPM) continues its upward trajectory, Augmentin by GlaxoSmithKline (GSK) has stood the ...

GSK said on Friday that its respiratory syncytial virus (RSV) vaccine has received approval in Japan for expanded use in ...

Analysis by SBM Intelligence showed that Nigeria's instability worsened as it ranked 45th position this year, unlike the ...

CVS Pharmacy is facing a proposed class-action lawsuit alleging that it misleadingly markets certain over-the-counter medications as "non-drowsy" despite t ...

The global over-the-counter (OTC) pain medication market is poised for steady growth, with its market size expected to attain ...

Vicebio Ltd (“Vicebio”), a biopharmaceutical company pioneering next-generation vaccines for life-threatening respiratory viruses, today announces its progress in the ongoing VXB-241 bivalent RSV-hMPV ...

The Competition Commission played a pivotal role in South Africa's historic fight for access to HIV medicines.